Hans Lindeberg Appointed to Lead ALK North America
/PRNewswire/ -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF) has appointed Hans Lindeberg as its new Senior Vice President of Commercial Operations in North...
Source: prnewswire.com
📰 Per Plotnikof News
Page 4 - Per Plotnikof News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Per Plotnikof. Real-time updates on events, politics, business and more.
Release date of three-month interim report (Q1) 2022 for ALK and audio cast
03.05.2022 - On Thursday, 12 May 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its three-month interim report (Q1) 2022. ALK will host a meeting for analysts and institutional investors that day at 1.30 pm (CEST) at which Management will review ...
Source: wallstreet-online.de
Clinical trial waiver in China opens door to 2022 registration filing for ALK's dust mite allergy tablet
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Release date of annual report 2021 for ALK and audio cast
On Tuesday, 8 February 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its annual report for 2021. ALK will host a meeting for analysts and...
Source: globenewswire.com
ALK Acquires OTIPRIO® (ciprofloxacin otic suspension), Broadening Treatment Solutions for Healthcare Providers and Patients
/PRNewswire/ -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of...
United States Stuart Loesch Jorge Alderete American Academy Of Otolaryngology Stalk Inc Neck Surgery Foundation
Source: prnewswire.com
Health Canada Approves ALK's RAGWITEK® Sublingual Allergy Immunotherapy (SLIT)-Tablets for Pediatric Patients with Ragweed Allergy
Share this article Share this article - With the indication expanded to pediatric patients, ALK Canada now provides adults and children a SLIT-tablet option to treat allergies to ragweed pollen, one of the most common allergens found in the provinces of Ontario and Quebec - MISSISSAUGA, ON, Dec. 22, 2020 /CNW/ -- Today ALK, a global, research-driven pharmaceutical company, announced that Health Canada has approved once-daily RAGWITEK® (Standardized Allergen Extract, Short Ragweed (Ambrosia art...
Source: newswire.ca